Current Bioactive Compounds
Title: Editorial [Hot Topic: New Paradigms in Drug Formulation and Phytotherapeutics (Guest Editor: Shyam M. Rele)]
Volume: 4 Issue: 4
Author(s): Shyam M. Rele
Affiliation:
Export Options
About this article
Cite this article as:
Rele M. Shyam, Editorial [Hot Topic: New Paradigms in Drug Formulation and Phytotherapeutics (Guest Editor: Shyam M. Rele)], Current Bioactive Compounds 2008; 4 (4) . https://dx.doi.org/10.2174/157340708786847898
DOI https://dx.doi.org/10.2174/157340708786847898 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Interactions Between the C-Terminus of Aβ-Peptide and Phospholipase A<sub>2</sub> - A Structure Biology Based Approach to Identify Novel Alzheimer's Therapeutics
CNS & Neurological Disorders - Drug Targets Pediatric Obesity Epidemic: Problem and Solutions
Current Pharmaceutical Design Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters
Endocrine, Metabolic & Immune Disorders - Drug Targets Immune Regulation by the Posttranslational Modification O-GlcNAc
Current Signal Transduction Therapy Various Non-Injectable Delivery Systems for the Treatment of Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities
Current Vascular Pharmacology Regulation of Endochondral Ossification by Osteogenic Growth Peptide CTerminal Pentapeptide [OGP(10-14)]
Protein & Peptide Letters Menopause and its Cardiometabolic Consequences: Current Perspectives
Current Vascular Pharmacology Individual Differences and Vulnerability to Drug Addiction: A Focus on the Endocannabinoid System
CNS & Neurological Disorders - Drug Targets Anticonvulsant Action and Long-term Effects of Gabapentin
Current Neuropharmacology Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade
Endocrine, Metabolic & Immune Disorders - Drug Targets Anemia in Patients with Diabetic Foot Ulcer: Effects on Diabetic Microvascular Complications and Related Conditions
Endocrine, Metabolic & Immune Disorders - Drug Targets Rituximab Treatment Modulates the Release of Hydrogen Peroxide and the Production of Proinflammatory Cytokines by Monocyte at the Onset of Type 1 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Adipocytes Derived from Human Bone Marrow Mesenchymal Stem Cells Exert Inhibitory Effects on Osteoblastogenesis
Current Molecular Medicine Contrast Medium Induced Nephropathy: New Insights into Prevention and Risk Management
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial (Hot Topic: Antioxidant Heterocyclic Compounds in Drug Discovery and Medicinal Chemistry)
Mini-Reviews in Medicinal Chemistry Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management
Current Pharmaceutical Design Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry: An Attractive and Prospective Method for Quantitative Bioanalysis in Drug Metabolism
Current Drug Metabolism Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes
Endocrine, Metabolic & Immune Disorders - Drug Targets Lepidine B & E as New Target Inhibitors from Lepidium Sativum Seeds Against Four Enzymes of the Pathogen Candida albicans: In Vitro and In Silico Studies
Endocrine, Metabolic & Immune Disorders - Drug Targets